Greenwich LifeSciences, Inc.
Greenwich LifeSciences, Inc. (GLSI) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
glsi · pe ratio · data through Dec 31, 2025
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Greenwich LifeSciences, Inc. (GLSI) measures how much investors pay for each dollar of the company's trailing earnings. GLSI's current PE ratio of N/A is calculated by dividing its stock price of $22.49 by its TTM earnings per share of -$1.49.
Source: FMP · /ratios-ttm · /analyst-estimates · 2025-12-31
PE Ratio History
2017 – 2025 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Biotechnology · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Greenwich LifeSciences, Inc.You GLSI | $330M | N/A | — | -$1.49 |
 Agenus Inc. AGEN | $135M | 811.87x | — | $0.00 |
 Atossa Therapeutics, Inc. ATOS | $39M | N/A | — | -$4.04 |
 Cognition Therapeutics, Inc. CGTX | $89M | N/A | — | -$0.32 |
 TuHURA Biosciences, Inc. HURA | $133M | N/A | — | -$0.63 |
 Immix Biopharma, Inc. IMMX | $435M | N/A | — | -$0.89 |
 Opus Genetics, Inc. IRD | $330M | N/A | — | -$0.08 |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2025-12-31Latest FY2025 | — | $-1.43 | — | |
2024-12-31 FY2024 | — | $-1.21 | — | |
2023-12-31 FY2023 | — | $-0.69 | — | |
2022-12-31 FY2022 | — | $-0.61 | — | |
2021-12-31 FY2021 | — | $-0.35 | — | |
2020-12-31 FY2020 | — | $-0.15 | — | |
2019-12-31 FY2019 | — | $-0.29 | — | |
2018-12-31 FY2018 | — | $-0.14 | — | |
2017-12-31 FY2017 | — | $-0.13 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Greenwich LifeSciences, Inc. (GLSI) measures how much investors pay for each dollar of the company's trailing earnings. GLSI's current PE ratio of N/A is calculated by dividing its stock price of $22.49 by its TTM earnings per share of -$1.49.
Frequently asked questions
GLSI pe ratio · 6 questionsGLSI's current PE ratio is N/A as of 2026-06-09, based on a stock price of $22.49 and TTM EPS of -$1.49. Data sourced from Financial Modeling Prep via GLSI's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Greenwich LifeSciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09